The estimated Net Worth of Marlan D Walker is at least $145 Thousand dollars as of 5 December 2023. Mr. Walker owns over 70,000 units of TherapeuticsMD stock worth over $145,103 and over the last 3 years he sold TXMD stock worth over $0. In addition, he makes $0 as General Counsel at TherapeuticsMD.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Walker TXMD stock SEC Form 4 insiders trading
Marlan has made over 5 trades of the TherapeuticsMD stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 70,000 units of TXMD stock worth $124,453 on 5 December 2023.
The largest trade he's ever made was exercising 230,000 units of TherapeuticsMD stock on 14 March 2022 worth over $408,917. On average, Marlan trades about 32,778 units every 85 days since 2021. As of 5 December 2023 he still owns at least 81,615 units of TherapeuticsMD stock.
You can see the complete history of Mr. Walker stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Marlan Walker biography
Marlan Walker J.D. serves as General Counsel of the Company. Mr. Walker previously also served as Chief Development Officer from April 2018 to December 2019 and as our Corporate and Intellectual Property Counsel from June 2013 until he became our General Counsel. Mr. Walker’s experience is focused in management of legal issues and risk in the life science industries across a variety of disciplines. His legal practice prior to his time at TherapeuticsMD included long-term portfolio strategy and management, patent preparation and prosecution, contract negotiation and drafting, life-cycle management, and Hatch-Waxman. After law school, he took a position at Greenberg Traurig, LLP in August 2005. In March of 2009, he moved to Luce Forward Hamilton & Scripps. Mr. Walker graduated from Arizona State University’s Sandra Day O’Conner College of Law with his J.D. in 2004, and an LL.M. in Intellectual Property Law at The George Washington University Law School in 2005. He holds a Master’s Degree in Molecular Biology and a B.S. degree, both earned from Brigham Young University.
How old is Marlan Walker?
Marlan Walker is 45, he's been the General Counsel of TherapeuticsMD since 2016. There are 22 older and 4 younger executives at TherapeuticsMD. The oldest executive at TherapeuticsMD, Inc. is Tommy Thompson, 78, who is the Independent Chairman of the Board.
What's Marlan Walker's mailing address?
Marlan's mailing address filed with the SEC is 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431.
Insiders trading at TherapeuticsMD
Over the last 13 years, insiders at TherapeuticsMD have traded over $60,334,483 worth of TherapeuticsMD stock and bought 3,746,989 units worth $33,644,571 . The most active insiders traders include Cooper C. Collins, Brian Bernick, and Robert G Finizio. On average, TherapeuticsMD executives and independent directors trade stock every 30 days with the average trade being worth of $233,918. The most recent stock trade was executed by Cooper C. Collins on 22 August 2024, trading 4,094 units of TXMD stock currently worth $7,083.
What does TherapeuticsMD do?
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17Ã-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-007HR and TX-008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
What does TherapeuticsMD's logo look like?
Complete history of Mr. Walker stock trades at TherapeuticsMD
TherapeuticsMD executives and stock owners
TherapeuticsMD executives and other stock owners filed with the SEC include:
-
John Milligan,
President, Secretary -
Brian Bernick,
Co-Founder -
Robert Finizio,
Chief Executive Officer and Director -
Robert G. Finizio,
Co-Founder & Vice Chair -
Mitchell Krassan,
Chief Strategy and Performance Officer -
John C. K. Milligan IV,
Chief Exec. Officer of VitaCare Prescription Services -
Michael Donegan,
Vice President - Finance -
Tommy Thompson,
Independent Chairman of the Board -
Cooper Collins,
Independent Director -
J. Martin Carroll,
Independent Director -
Angus Russell,
Independent Director -
Jules Musing,
Independent Director -
Dr. Brian A. Bernick,
Co-Founder & Chief Scientific Officer -
Nichol Ochsner,
Vice President, Investor Relations -
Gail Naughton,
Independent Director -
Karen Ling,
Independent Director -
Paul Bisaro,
Independent Director -
Bharat Warrier,
Chief Manufacturing Officer -
Sebastian Mirkin,
Chief Medical Officer -
Dawn Halkuff,
Chief Commercial Officer -
Marlan Walker,
General Counsel -
John Knighton,
Chief Compliance Officer -
Adam Miller,
Chief Information Officer -
James D'Arecca,
Chief Financial Officer -
Julia M. Amadio,
Chief Product Officer -
Mitchell L. Krassan,
Exec. VP and Chief Strategy & Performance Officer -
Michael Donegan,
Chief Accounting Officer & VP of Fin. -
James C. D'Arecca,
Chief Financial Officer -
Hugh O'Dowd M.B.A.,
Pres, CEO & Director -
Robert V Jr La Penta,
Director -
Nicholas Segal,
Director -
Daniel A Cartwright,
Chief Financial Officer -
Capital Management Lp Rosen...,
-
Jane F Barlow,
Director -
Samuel A Greco,
Director -
Randall S Stanicky,
Director -
Edward Borkowski,
EVP, Operations -
Hugh O'dowd,
Chief Executive Officer -
Mark A Glickman,
Co-Chief Executive Officer -
Joseph Ziegler,
Principal Financial Officer